- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Alpha-Linolenic Acid-Enriched Diacylglycerol Oil Suppresses the Postprandial Serum Triglyceride Level—A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
-
- YAMANAKA Nami
- Health Care Food Research Laboratories, Kao Corporation
-
- SAITO Shinichiro
- Health Care Food Research Laboratories, Kao Corporation
-
- OSAKI Noriko
- Health Care Food Research Laboratories, Kao Corporation
-
- KAMEI Sakura
- Medical Corporation Souseikai, Sumida Hospital
-
- NAKAMURA Haruo
- Mitsukoshi Health and Welfare Foundation
-
- KATSURAGI Yoshihisa
- Health Care Food Research Laboratories, Kao Corporation
Bibliographic Information
- Other Title
-
- Alpha-Linolenic Acid-Enriched Diacylglycerol Oil Suppresses the Postprandial Serum Triglyceride Level : A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
- Alpha-Linolenic Acid-Enriched Diacylglycerol Oil Suppresses the Postprandial Serum Triglyceride Level—A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Search this article
Description
This study investigated the effect of a single oral ingestion of alpha-linolenic acid-enriched diacylglycerol (ALA-DAG) on postprandial serum triglyceride (TG) levels. A randomized, double-blind, controlled, crossover study was performed in subjects with normal or moderately high fasting serum TG levels. Subjects ingested 0.00 g [control: triacylglycerol; TAG (rapeseed oil)], 1.25 g (1.25-g: mixture of 1.25 g ALA-DAG and 1.25 g TAG), or 2.50 g (2.50 g) of ALA-DAG in random order with a 6-d washout period. Serum TG levels were evaluated in the fasting state, and at 2, 3, 4, and 6 h after the test meal. Thirty-eight subjects completed the study and were defined as the per protocol set. As the primary outcome, postprandial serum TG levels were significantly lower in the 2.50-g treatment compared with the control. The TG level did not differ significantly between the 1.25-g and control. The suppressive effect of ALA-DAG on the serum TG level correlated significantly with the body mass index and fasting insulin level. ALA-DAG at a dose of 2.50 g had greater effects on serum TG and apolipoprotein B levels in subjects with a higher body mass index (≥25 kg/m2) and higher fasting serum insulin levels (>10 μU/mL). Our findings suggest that ingesting 2.50 g ALA-DAG suppresses the postprandial serum TG level in people with normal and moderately high fasting serum TG levels, presumably as a result of poor re-esterification of dietary fat into TG in the intestinal mucosa.
Journal
-
- Journal of Nutritional Science and Vitaminology
-
Journal of Nutritional Science and Vitaminology 62 (6), 402-408, 2016
Center for Academic Publications Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390001206323844608
-
- NII Article ID
- 130005332259
-
- NII Book ID
- AA00703822
-
- ISSN
- 18817742
- 03014800
-
- NDL BIB ID
- 027809779
-
- PubMed
- 28202845
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed